title: Barriers to new drug development in respiratory disease.
authors.affiliation: Médecins Sans Frontières, Geneva, Switzerland graniabrigden@doctors.org.uk.
authors.forename: Grania
authors.initials: G
authors.lastname: Brigden
authors.affiliation: Médecins Sans Frontières, London, UK.
authors.forename: Philipp
authors.initials: P
authors.lastname: du Cros
authors.affiliation: Médecins Sans Frontières, Operational Centre Amsterdam, Amsterdam, The Netherlands.
authors.forename: Sidney
authors.initials: S
authors.lastname: Wong
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D001363:Awards and Prizes; D064687:Diarylquinolines / Q000627:therapeutic use; D055808:Drug Discovery; D054908:Extensively Drug-Resistant Tuberculosis / Q000188:drug therapy*; D006801:Humans; D009042:Motivation; D009593:Nitroimidazoles / Q000627:therapeutic use; D010080:Oxazoles / Q000627:therapeutic use; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy
chemical_list: D000995:Antitubercular Agents; D064687:Diarylquinolines; D009593:Nitroimidazoles; C516022:OPC-67683; D010080:Oxazoles; C493870:bedaquiline